These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23823996)

  • 1. Genetic study confirms causal link between adiposity and cardiometabolic disease.
    BMJ; 2013 Jul; 347():f4199. PubMed ID: 23823996
    [No Abstract]   [Full Text] [Related]  

  • 2. Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?
    Milewicz A; Tworowska-Bardzińska U; Jędrzejuk D; Lwow F; Dunajska K; Łaczmański Ł; Pawlak M
    Int J Obes (Lond); 2011 Mar; 35(3):373-7. PubMed ID: 20838400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome.
    Dulloo AG; Jacquet J; Seydoux J; Montani JP
    Int J Obes (Lond); 2006 Dec; 30 Suppl 4():S23-35. PubMed ID: 17133232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of stress to the development of the metabolic syndrome. In memory of Per Bjorntorp (1931-2003)].
    Rosmond R
    Lakartidningen; 2004 Apr; 101(15-16):1371-5. PubMed ID: 15146663
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation.
    Martin S; Tyrrell J; Thomas EL; Bown MJ; Wood AR; Beaumont RN; Tsoi LC; Stuart PE; Elder JT; Law P; Houlston R; Kabrhel C; Papadimitriou N; Gunter MJ; Bull CJ; Bell JA; Vincent EE; Sattar N; Dunlop MG; Tomlinson IPM; Lindström S; ; Bell JD; Frayling TM; Yaghootkar H
    Elife; 2022 Jan; 11():. PubMed ID: 35074047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of ethnicity, including those of mixed ethnicity.
    Wells JC
    Obes Rev; 2012 Dec; 13 Suppl 2():14-29. PubMed ID: 23107256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition phenotypes in pathways to obesity and the metabolic syndrome.
    Dulloo AG; Jacquet J; Solinas G; Montani JP; Schutz Y
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S4-17. PubMed ID: 21151146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
    Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal association between adiposity and cardiovascular disease.
    Larsson SC
    Eur Heart J; 2019 Sep; 40(35):2937-2938. PubMed ID: 31520584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method].
    Nilsson PM
    Lakartidningen; 2013 Apr 17-23; 110(16):832-5. PubMed ID: 23717930
    [No Abstract]   [Full Text] [Related]  

  • 11. Using Mendelian randomization to determine causative factors in cardiovascular disease.
    Johansen CT; Hegele RA
    J Intern Med; 2013 Jan; 273(1):44-7. PubMed ID: 22928522
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF7L2 alleles and metabolic syndrome in non-diabetic obese hypertensive patients.
    Sarzani R; Salvi F; Bordicchia M; Pietrucci F; Caraceni D; Lancioni L; Dessí-Fulgheri P; Rappelli A
    J Hum Hypertens; 2008 May; 22(5):373-5. PubMed ID: 18288125
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic and epigenetic studies of adiposity and cardiometabolic disease.
    Holmes MV; Pulit SL; Lindgren CM
    Genome Med; 2017 Sep; 9(1):82. PubMed ID: 28923095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.
    Amato MC; Verghi M; Galluzzo A; Giordano C
    Hum Reprod; 2011 Jun; 26(6):1486-94. PubMed ID: 21447694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.
    Rosenson RS; Hurt-Camejo E
    J Am Coll Cardiol; 2014 Mar; 63(9):942-3. PubMed ID: 24315918
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic variation in HDL-related genes and the association with cardiovascular disease: HDL particles as chameleons of lipoprotein metabolism.
    Kronenberg F
    J Intern Med; 2011 Aug; 270(2):128-31. PubMed ID: 21575086
    [No Abstract]   [Full Text] [Related]  

  • 18. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A variant in the LRRFIP1 gene is associated with adiposity and inflammation.
    Plourde M; Vohl MC; Bellis C; Carless M; Dyer T; Dolley G; Marette A; Després JP; Bouchard C; Blangero J; Pérusse L
    Obesity (Silver Spring); 2013 Jan; 21(1):185-92. PubMed ID: 23505185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
    Thanassoulis G
    Can J Cardiol; 2013 Jan; 29(1):30-6. PubMed ID: 23199790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.